SULVORID Tablet Ref.[51045] Active ingredients: Levosulpiride

Source: Υπουργείο Υγείας (CY)  Revision Year: 2019  Publisher: Codal-Synto Ltd, 21 Constantinoupoleos Street, 3011 Limassol, Cyprus

4.1. Therapeutic indications

  • Endogenous and reactive depression.
  • Somatoform disorders.
  • Acute and chronic schizophrenia.

4.2. Posology and method of administration

Posology

Adults

Adults and acute forms of mental disorders: 2-3 tablets of 100 mg per day.

Maintenance therapy: unless otherwise prescribed 3 tablets of 50 mg per day.

This dose may be gradually reduced.

Peadiatric population

No data are available.

Elderly

In the treatment of elderly patients, the dosage should be decided by the physician which must carefully evaluate a possible reduction of the dosages above mentioned.

4.9. Overdose

The medicine can induce extrapyramidal effects and sleep disorders, at higher doses and in patients sensitive to neuroleptics.

In these cases it will be advisable to reduce the dosage or discontinue the treatment, according to the physician decision.

6.3. Shelf life

3 years.

6.4. Special precautions for storage

This medicinal product does not require any special storage precautions.

6.5. Nature and contents of container

Packs of 20, 30, 60 and 100 tablets packed in blisters (PVC/PVDC/Al or PVC/PCTFE/Al).

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.